CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 38 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,124,000 | +4.9% | 391,135 | +16.1% | 0.00% | 0.0% |
| Q3 2016 | $4,883,000 | +29.7% | 336,772 | +7.3% | 0.00% | 0.0% |
| Q2 2016 | $3,765,000 | -20.5% | 313,978 | +23.6% | 0.00% | 0.0% |
| Q1 2016 | $4,738,000 | -15.8% | 254,026 | -2.9% | 0.00% | 0.0% |
| Q4 2015 | $5,624,000 | +30.2% | 261,716 | +2.6% | 0.00% | 0.0% |
| Q3 2015 | $4,320,000 | -55.3% | 255,165 | -1.1% | 0.00% | -50.0% |
| Q2 2015 | $9,673,000 | – | 257,876 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|